All systems operational
For Researchers
For Publishers
Login
Register
عربي
Submit Journal
عربي
Navigation
01
Discover
02
Rankings
03
For Publishers
04
About AMS
Back to Menu
Discover
By type
Journals
Research Papers
Authors
Institutions
Publishers
Affiliates
By Field
Medicine & Health Sciences
Engineering & Technology
Natural Sciences
Social Sciences
Computer Science & AI
All 98 fields →
By Country
🇸🇦 Saudi Arabia
🇪🇬 Egypt
🇯🇴 Jordan
🇦🇪 UAE
🇲🇦 Morocco
All 22 countries →
Tools
DOI Lookup
ISSN Search
Rankings
Journal rankings
AMS Score Ranking
Citation Impact (CIF)
Quartile Rankings Q1–Q4
Open Access Index
Rising Stars
People & places
Authors Ranking
Institutions Ranking
Country Ranking
By subject
Medicine & Health
Engineering
Computer Science
Natural Sciences
All rankings →
For Publishers
Get indexed
Journal Indexing
Indexing Criteria
Packages & Pricing
Review Timeline
Benefits
Global visibility — 22 countries
AMS Score badge
AMS Certification
Real-time analytics dashboard
REST API access
Resources
Publisher Sign In
Register
API Documentation
Publisher FAQ
About AMS
Platform
What is AMS?
Our Methodology
Quality Standards
News & Updates
Technical
API Documentation
Data Sources
System Status
Resources
Research Reports
Annual Statistics
Press Kit
FAQ
Contact Us
Login
Register
Affiliates
For Researchers
Submit Journal
Home
Authors
Ezzat Safwat
ES
Ezzat Safwat
h-4
H-Index
36
Citations
5
Papers
Published Papers
5 indexed
1
The KRAS StripAssay for detection of KRAS mutation in Egyptian patients with colorectal cancer (CRC): A pilot study
Journal of the Egyptian National Cancer Institute
Q1
2013
10.1016/j.jnci.2012.12.003
11
citations
376
2
Novel mutations of the nucleophosmin (NPM-1) gene in Egyptian patients with acute myeloid leukemia: A pilot study
Journal of the Egyptian National Cancer Institute
Q1
2011
10.1016/j.jnci.2011.09.003
9
citations
379
3
Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy
Journal of the Egyptian National Cancer Institute
Q1
2017
10.1016/j.jnci.2017.05.001
8
citations
375
4
Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy
Journal of the Egyptian National Cancer Institute
Q1
2017
10.1016/j.jnci.2017.05.001
8
citations
376
5
Corrigendum to “Novel mutations of the nucleophosmin (NPM-1) gene in Egyptian patients with acute myeloid leukemia: A pilot study” [Journal of the Egyptian National Cancer Institute 23 (2011) 73–78]
Journal of the Egyptian National Cancer Institute
Q1
2012
10.1016/j.jnci.2012.02.003
0
citations
382
Publication Activity
Journals Published In
JOT
Journal of the Egyptian National Cancer Institute
🇪🇬
Q1
AMS 94